Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
86 hedge funds and large institutions have $149M invested in Molecular Templates, Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 11 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 23
0% more funds holding
Funds holding: 86 → 86 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
14% less capital invested
Capital invested by funds: $172M → $149M (-$23.4M)
14% less call options, than puts
Call options by funds: $317K | Put options by funds: $367K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
+$2.26M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$1.84M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$1.81M |
| 4 |
Renaissance Technologies
New York
|
+$1.34M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.77M |
| 2 |
JP Morgan Chase
New York
|
-$2.51M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.5M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.17M |
| 5 |
Morgan Stanley
New York
|
-$998K |
MTEM Hedge Fund Activity: Q3 2013 in Review
86 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q3 2013, worth a combined $149M — down 14% from $172M a quarter earlier.
Fund positioning in MTEM was balanced in Q3 2013: 11 funds opened new positions, 11 closed out, 33 added to existing stakes and 23 trimmed.
The largest buyer was CR Intrinsic Investors, opening a new position worth an estimated $2.26M. The largest seller was Fidelity Investments, cutting an estimated $8.77M.
- 86 institutional investors held Molecular Templates, Inc. (MTEM) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $149M of Molecular Templates, Inc. stock for Q3 2013, down 14% quarter-over-quarter.
- 11 funds opened new Molecular Templates, Inc. positions in Q3 2013 and 11 closed out, a net change of 0 holders.
- The largest Molecular Templates, Inc. buyer in Q3 2013 was CR Intrinsic Investors, an estimated $2.26M added.
- The largest Molecular Templates, Inc. seller in Q3 2013 was Fidelity Investments, an estimated $8.77M sold.
Based on aggregated 13F filings for Q3 2013.